Robenacoxib is a nonsteroidal anti-inflammatory drug used to treat pain and inflammation in dogs and cats.

.

. .

Telmisartan may cause birth defects and should not be.

.

Most common side effects: Ptyalism was routinely noted in both efficacy and safety studies, occurring soon after administration. Description. It may also be used as a treatment for congestive heart failure, systemic hypertension, or pulmonary hypertension in dogs.

.

If you are to miss a dose, do not increase the dose or. Aug 25, 2021 · SEMINTRA may cause inappetence and weight loss in some cats. 2011028 and 2011029).

In a blinded randomised controlled clinical study adverse reactions were rare. Oct 2, 2018 · The most common side effects reported in field studies include vomiting, diarrhea, lethargy, anemia, dehydration, poor appetite, and weight loss.

2011028 and 2011029).

Semintra is a prescription product.

The most common side effects seen with Semintra are mild and short- lived vomiting and diarrhoea (which may affect up to 1 in 10 cats treated with the 10 mg/ml strength solution ). .

The safe use of SEMINTRA in cats with hepatic disease has not been evaluated. cats or in cats under the age of 6 months.

.
.
About Semintra ®.

Vomiting.

The most common side effects seen with Semintra are mild and short- lived vomiting and diarrhoea (which may affect up to 1 in 10 cats treated with the 10 mg/ml strength solution.

. The safe use of SEMINTRA in cats with hepatic disease has not been evaluated. Use with caution in cats with a history of vomiting, inappetence or weight loss.

Prescribed by your veterinarian, SEMINTRA is an easy-to-give liquid medication that’s designed to provide safe and effective long-term control of high blood pressure in cats. It is licensed for the reduction of proteinuria (i. Cats should be monitored for weight loss when initiating treatment with SEMINTRA. . Telmisartan may cause birth defects and should not be. .

When starting treatment, veterinarians should monitor all cats for anemia and a decreased appetite resulting in weight loss.

It is licensed for the reduction of proteinuria (i. The safe use of SEMINTRA in cats with hepatic disease has not been evaluated.

Are there any potential side effects? Side effects may include vomiting, diarrhea, lack of appetite, low blood pressure, and decreased energy.

It may also be used as a treatment for congestive heart failure, systemic hypertension, or pulmonary hypertension in dogs.

.

cats or in cats under the age of 6 months.

SEMINTRA is metabolized by the liver.